Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

June 15, 2026 updated by: Pfizer

Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to < 18 years of age).

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
600

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Poland
      • Katowice, Poland, 40-123
        • Terminated
        • NZOZ Wielospecjalistyczna Poradnia Lekarska SYNAPSIS, Lech Szczechowski
      • Krakow, Poland, 30-363
        • Recruiting
        • Centrum Medyczne Plejady
        • Contact:
      • Krakow, Poland, 31-503
        • Recruiting
        • Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie Oddzial Kliniczny Dzieci
      • Poznan, Poland, 60-848
        • Recruiting
        • Clinical Research Center Sp. z o.o.
      • Wroclaw, Poland, 52-416
        • Active, not recruiting
        • Centrum Medyczne Oporow
      • Wroclaw, Poland, 52-210
        • Recruiting
        • Pracownia Badan Klinicznych SALUS
  • Spain
      • Barcelona, Spain, 08035
        • Recruiting
        • Hospital Universitario Vall d'Hebron
      • Seville, Spain, 41013
        • Recruiting
        • Hospital Universitario Virgen del Rocío
      • Valladolid, Spain, 47003
        • Recruiting
        • Hospital Clinico Universitario de Valladolid
    • Barcelona
      • Balenya, Barcelona, Spain, 08550
        • Active, not recruiting
        • Centre Atencio Primaria (CAP) Balenya
  • United States
    • Arizona
      • Scottsdale, Arizona, United States, 85253
        • Recruiting
        • Perseverance Research Center, LLC
      • Tempe, Arizona, United States, 85284
        • Active, not recruiting
        • Physicians Research Group
    • California
      • Anaheim, California, United States, 92805
        • Recruiting
        • Advanced Research Center, Inc.
        • Contact:
      • Culver City, California, United States, 90230
        • Active, not recruiting
        • ProScience Research Group
      • Fresno, California, United States, 93710
        • Recruiting
        • Neuro-Pain Research Center
      • La Jolla, California, United States, 93037
        • Recruiting
        • Altman Clinical and Translational Research Institute, University of California San Diego
      • Long Beach, California, United States, 90806
        • Recruiting
        • Memorialcare Miller Children's & Women's Hospital Long Beach
      • Long Beach, California, United States, 90806
        • Recruiting
        • Adult & Child Neurology Medical Associates
      • North Hollywood, California, United States, 91606
        • Active, not recruiting
        • Velocity Clinical Research - North Hollywood
      • Pomona, California, United States, 91767
        • Recruiting
        • The Neurology Group
        • Contact:
      • Sacramento, California, United States, 95817
        • Active, not recruiting
        • UC Davis Medical Center, Investigational Drug Service (IDS) Pharmacy
      • Sacramento, California, United States, 95817
        • Active, not recruiting
        • University of California, Davis Clinical and Translational Science Center Clinical Research Center
      • Sacramento, California, United States, 95817
        • Active, not recruiting
        • University of California, Davis Midtown Clinic
      • San Bernardino, California, United States, 92408
        • Recruiting
        • Velocity Clinical Research- Banning
      • Upland, California, United States, 91786
        • Active, not recruiting
        • Pacific Clinical Research Management Group LLC
      • Walnut Creek, California, United States, 94596
        • Recruiting
        • Sunwise Clinical Research
    • Colorado
      • Aurora, Colorado, United States, 80045
        • Recruiting
        • Children's Hospital Colorado
      • Aurora, Colorado, United States, 80045
        • Recruiting
        • Children's Hospital Colorado- Investigational Drug Services
      • Colorado Springs, Colorado, United States, 80907
        • Active, not recruiting
        • Colorado Springs Neurological Associates, PC
      • Colorado Springs, Colorado, United States, 80919
        • Active, not recruiting
        • Colorado Springs Neurological Associates, PC
      • Grand Junction, Colorado, United States, 81501
        • Terminated
        • Boeson Research GJT
      • Grand Junction, Colorado, United States, 81501
        • Terminated
        • Dinosaur Pediatrics
      • Grand Junction, Colorado, United States, 81505
        • Terminated
        • Boeson Research GJT
    • Connecticut
      • Cromwell, Connecticut, United States, 06416
      • Stamford, Connecticut, United States, 06905
        • Recruiting
        • Ki Health Partners, LLc, dba New England Institute for Clinical Research
    • District of Columbia
      • Washington D.C., District of Columbia, United States, 20010
        • Recruiting
        • Children's National Medical Center
    • Florida
      • Miami, Florida, United States, 33134
        • Active, not recruiting
        • Medical Research Center of Miami II, Inc
      • Miami, Florida, United States, 33126
        • Active, not recruiting
        • AppleMed Research Group, LLC
      • Miami, Florida, United States, 33166
        • Recruiting
        • South Florida Research Phase I-IV, Inc
      • Orange Park, Florida, United States, 32073
        • Active, not recruiting
        • Physicians Group Services, PA d/b/a Coastal Health Research
      • Orlando, Florida, United States, 32819
      • Tampa, Florida, United States, 33613
        • Active, not recruiting
        • Forcare Clinical Research
      • West Palm Beach, Florida, United States, 33407
        • Active, not recruiting
        • Premiere Research Institute at Palm Beach Neurology
    • Georgia
      • Atlanta, Georgia, United States, 30329
        • Active, not recruiting
        • Rare Disease Research LLC
      • Atlanta, Georgia, United States, 30329
        • Recruiting
        • Childrens Healthcare of Atlanta
      • Brunswick, Georgia, United States, 31520
        • Recruiting
        • Pivotal Clinical Research & Associates, LLC
      • Decatur, Georgia, United States, 30030
        • Recruiting
        • CenExel iResearch, LLC
    • Illinois
      • Chicago, Illinois, United States, 60657
        • Recruiting
        • Chicago Headache Center & Research Institute
      • Naperville, Illinois, United States, 60563
        • Recruiting
        • AMR-Baber Research Inc
    • Indiana
      • Westfield, Indiana, United States, 46074
        • Recruiting
        • Options Research Group, LLC
    • Iowa
      • West Des Moines, Iowa, United States, 50265
        • Recruiting
        • Integrated Clinical Trial Services
    • Kansas
      • Kansas City, Kansas, United States, 66214
        • Recruiting
        • Clinical Associates Midwest, LLC
    • Kentucky
      • Lexington, Kentucky, United States, 40536
        • Active, not recruiting
        • University of Kentucky Hospital
    • Louisiana
      • New Orleans, Louisiana, United States, 70121
        • Terminated
        • Ochsner Clinic Foundation
    • Massachusetts
      • Waltham, Massachusetts, United States, 02451
        • Active, not recruiting
        • MedVadis Research Corporation
    • Michigan
      • Ann Arbor, Michigan, United States, 48104
        • Recruiting
        • Michigan Head Pain and Neurological Institute
      • Grand Rapids, Michigan, United States, 49503
        • Recruiting
        • Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group
      • Grand Rapids, Michigan, United States, 49503
        • Recruiting
        • Corewell Health, Helen DeVos Children's Hospital
      • Kalamazoo, Michigan, United States, 49048
        • Terminated
        • Wellnow Urgent Care and Research
      • Royal Oak, Michigan, United States, 48073
        • Recruiting
        • Beaumont Hospital, Royal Oak Campus
    • Missouri
      • Ozark, Missouri, United States, 65721
        • Active, not recruiting
        • Sharlin Health Neuroscience Research Center
      • Springfield, Missouri, United States, 65807
        • Active, not recruiting
        • Clinvest Research, LLC
    • Montana
      • Great Falls, Montana, United States, 59405
        • Recruiting
        • Boeson Research
      • Kalispell, Montana, United States, 59901
        • Active, not recruiting
        • Heart & Hands Midwifery
      • Missoula, Montana, United States, 59804
        • Recruiting
        • Boeson Research
      • Missoula, Montana, United States, 59804
        • Recruiting
        • Blue Moose Pediatrics
      • Missoula, Montana, United States, 59804
        • Recruiting
        • Boeson Research Laboratory
    • Nebraska
      • Lincoln, Nebraska, United States, 68526
        • Terminated
        • Alivation Research, LLC
      • Omaha, Nebraska, United States, 68114
        • Recruiting
        • Children's Hospital & Medical Center
    • New Jersey
      • Neptune City, New Jersey, United States, 07753
        • Recruiting
        • HMH Jersey Shore University Medical Center
      • Neptune City, New Jersey, United States, 07753
        • Recruiting
        • Hope Tower
    • New York
      • Amherst, New York, United States, 14226
        • Recruiting
        • Dent Neurosciences Research Center
      • Commack, New York, United States, 11725
        • Recruiting
        • True North Neurology
      • New York, New York, United States, 10032
        • Active, not recruiting
        • Columbia University Irving Medical Center
      • New York, New York, United States, 10003
      • New York, New York, United States, 10029
        • Active, not recruiting
        • Mount Sinai Hospital - Pharmacy Department
      • New York, New York, United States, 10032
        • Active, not recruiting
        • Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit
      • New York, New York, United States, 10032
        • Active, not recruiting
        • The Neurological Institute of New York
      • Port Jefferson Station, New York, United States, 11776
        • Active, not recruiting
        • North Suffolk Neurology
    • North Carolina
      • Charlotte, North Carolina, United States, 28277
        • Recruiting
        • OnSite Clinical Solutions, LLC
      • Greensboro, North Carolina, United States, 27405
        • Recruiting
        • Headache Wellness Center, PC
    • Ohio
      • Cincinnati, Ohio, United States, 45242
        • Recruiting
        • Velocity Clinical Research - Cincinnati
      • Cincinnati, Ohio, United States, 45229
        • Recruiting
        • Cincinnati Children's Hospital
      • Cincinnati, Ohio, United States, 45215
        • Active, not recruiting
        • Wellnow Urgent Care and Research
      • Cleveland, Ohio, United States, 44106
        • Recruiting
        • University Hospitals Cleveland Medical Center
      • Dayton, Ohio, United States, 45424
        • Active, not recruiting
        • Wellnow Urgent Care and Research
    • Oklahoma
      • Oklahoma City, Oklahoma, United States, 73106
        • Active, not recruiting
        • IPS Research Company
    • Oregon
      • Grants Pass, Oregon, United States, 97527
        • Active, not recruiting
        • Velocity Clinical Research, Grants Pass
      • Portland, Oregon, United States, 97225
        • Recruiting
        • Providence Neuroscience Institute: Research Coordinators' Office
      • Portland, Oregon, United States, 97225
        • Recruiting
        • Providence Pediatric Specialty Clinic
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Active, not recruiting
        • Children's Hospital of Philadelphia
      • Philadelphia, Pennsylvania, United States, 19103
        • Active, not recruiting
        • Clario
    • Rhode Island
      • East Greenwich, Rhode Island, United States, 02818
        • Recruiting
        • Velocity Clinical Research-Providence
    • South Carolina
      • Greenville, South Carolina, United States, 29615
        • Active, not recruiting
        • Velocity Clinical Research- Greenville
      • Greer, South Carolina, United States, 29650
        • Active, not recruiting
        • Premier Neurology
    • Tennessee
      • Clarksville, Tennessee, United States, 37043
        • Active, not recruiting
        • Novaceut Clinical Research
      • Memphis, Tennessee, United States, 38103
        • Recruiting
        • Le Bonheur Children's Hospital
      • Memphis, Tennessee, United States, 38103
        • Recruiting
        • Le Bonheur Childrens Hospital - Childrens Foundation Research Institute
      • Memphis, Tennessee, United States, 38103
        • Recruiting
        • Le Bonheur Childrens Hospital - Outpatient Building
      • Nashville, Tennessee, United States, 37203
        • Terminated
        • Access Clinical Trials, Inc.
    • Texas
      • Austin, Texas, United States, 78723
        • Recruiting
        • Dell Children's Medical Center
      • Austin, Texas, United States, 78749
        • Recruiting
        • Child Neurology Consultants of Austin - South Austin
      • Austin, Texas, United States, 78757
        • Recruiting
        • Child Neurology Consultants of Austin - Central Austin
      • Bellaire, Texas, United States, 77401
        • Recruiting
        • Houston Clinical Trials, LLC
      • Dallas, Texas, United States, 75251
        • Active, not recruiting
        • Cedar Health Research
      • Dallas, Texas, United States, 75201
        • Active, not recruiting
        • Infinite Research Group, LLC
      • El Paso, Texas, United States, 79912
        • Recruiting
        • ANESC Research
      • Frisco, Texas, United States, 75034
        • Active, not recruiting
        • North Texas Institute of Neurology and Headache
      • Houston, Texas, United States, 77054
        • Recruiting
        • Pain and Headache Centers of Texas
        • Contact:
      • Houston, Texas, United States, 77094
        • Recruiting
        • NeuroCare Plus
      • Houston, Texas, United States, 77008
        • Active, not recruiting
        • Trio Clinical Trials, LLC.
      • Houston, Texas, United States, 77081
        • Terminated
        • Houston Clinical Research,LLC.
      • Houston, Texas, United States, 77077
        • Recruiting
        • SCLA Management
      • Plano, Texas, United States, 75093
        • Recruiting
        • AIM Trials, LLC
    • Utah
      • Salt Lake City, Utah, United States, 84107
        • Recruiting
        • JBR Clinical Research
        • Contact:
      • Salt Lake City, Utah, United States, 84107
        • Recruiting
        • Wasatch Clinical Research , LLC(Administrative Location)
    • Virginia
      • Charlottesville, Virginia, United States, 22902
        • Recruiting
        • Pediatric Research of Charlottesville, LLC
      • Charlottesville, Virginia, United States, 22902
        • Recruiting
        • Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice)
      • Charlottesville, Virginia, United States, 22902
        • Recruiting
        • Pediatric Research of Charlottesville, LLC (Regulatory Only)
      • Norfolk, Virginia, United States, 23507
        • Recruiting
        • Children's Hospital of The King's Daughters
      • Norfolk, Virginia, United States, 23510
        • Recruiting
        • Children's Specialty Group, PLLC , Division of Childhood & Adolescent Neurology
      • Richmond, Virginia, United States, 23294
        • Terminated
        • National Clinical Research, Inc.
    • Washington
      • Bellevue, Washington, United States, 98007
        • Recruiting
        • Northwest Clinical Research Center
        • Contact:
      • Seattle, Washington, United States, 98105
        • Recruiting
        • Seattle Children's Hospital
      • Seattle, Washington, United States, 98105
        • Recruiting
        • Seattle Children's Hospital Investigational Drug Services
    • Wisconsin
      • Madison, Wisconsin, United States, 53792
        • Recruiting
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

6 years to 18 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. History of migraine (with or without aura) for ≥ 6 months before Screening.
  2. History of 1 to 8 moderate or severe attacks per month during the 2 months prior to screening.
  3. 1 or more migraine days requiring treatment during the Observation Phase.
  4. Prophylactic migraine medication is permitted if the dose has been stable for at least 12 weeks prior to the Screening Visit.
  5. Ability to distinguish between migraine and other types of headaches.
  6. Weight > 15 kg. For EU countries only: Participants 12 to < 18 years of age must have a body weight of >25kg.
  7. Adequate venous access for blood sampling.
  8. Male and female participants 6 to < 18 years of age (participants must not reach their 18th birthday on or before the Baseline visit).

Exclusion Criteria:

  1. History of cluster headache or hemiplegic migraine headache.
  2. Confounding and clinically significant pain syndrome.
  3. Current uncontrolled and/or untreated psychiatric condition for a minimum of 6 months prior to the Screening Visit (lifetime history of psychosis and/or mania are excluded).
  4. History of suicidal behavior or at risk of self-harm/harm to others.
  5. History of major psychiatric disorder.
  6. Current diagnosis or history of substance abuse
  7. Reported current use of or tested positive at Screening for drugs of abuse.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Active
rimegepant 75 mg, 50 mg or 35 mg ODT
Drug: Rimegepant (PF-07899801)
Rimegepant 75 mg, 50 mg or 35 mg ODT

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The frequency and severity of on-treatment and treatment-emergent adverse events, serious adverse events, adverse events leading to discontinuation, clinically significant lab abnormalities
Time Frame: 58 weeks
To evaluate the safety and tolerability of rimegepant in children and adolescents (6 to < 18 years of age).
58 weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
The frequency and severity of hepatic-related adverse events and frequency of hepatic-related adverse events leading to treatment discontinuation
Time Frame: 58 weeks
To evaluate the frequency and severity of hepatic-related adverse events and the frequency of hepatic-related treatment discontinuations in children and adolescents (6 to less than 18 years of age) treated with rimegepant.
58 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Pfizer

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Pfizer CT.gov Call Center, Pfizer

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 28, 2021

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 31, 2030

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 31, 2030

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 4, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 5, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 8, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 16, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 15, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • BHV3000-312 (Alias Study Number)
  • C4951003 (Other Identifier: Alias Study Number)
  • 2024-512744-32-00 (Registry Identifier: CTIS (EU))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Treatment of Migraine

Clinical Trials on Rimegepant (PF-07899801)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings